These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
537 related items for PubMed ID: 3043338
1. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital]. Legrand P, Soussy CJ, Orsoni A, Brickley X, Duval J. Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338 [Abstract] [Full Text] [Related]
2. [Comparative activities of 15 beta-lactam antibiotics against 590 strains of Klebsiella pneumoniae according to the production of beta-lactamase]. Bercion R, Meyran M, Labia R, Thabaut A. Pathol Biol (Paris); 1991 May; 39(5):353-60. PubMed ID: 1881669 [Abstract] [Full Text] [Related]
3. In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins. Jarlier V, Nicolas MH, Philippon A, Giroir AM, Grosset J. J Antimicrob Chemother; 1989 Aug; 24(2):165-72. PubMed ID: 2676939 [Abstract] [Full Text] [Related]
4. [Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae]. Philippon A, Jarlier V, Legrand P, Fournier G, Nicolas MH, Duval J. Presse Med; 1989 Oct 11; 18(32):1560-6. PubMed ID: 2530532 [Abstract] [Full Text] [Related]
5. In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC beta-lactamase. Fernández-Cuenca F, Rodríguez-Martínez JM, Martínez-Martínez L, Pascual A. Int J Antimicrob Agents; 2006 Jun 11; 27(6):549-52. PubMed ID: 16697150 [Abstract] [Full Text] [Related]
6. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China]. Chen MJ, Wang H, China Nosocomial Pathogens Resistance Surveillance Study Group. Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):375-81. PubMed ID: 12820912 [Abstract] [Full Text] [Related]
7. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. Mushtaq S, Warner M, Ge Y, Kaniga K, Livermore DM. J Antimicrob Chemother; 2007 Aug 10; 60(2):300-11. PubMed ID: 17548456 [Abstract] [Full Text] [Related]
8. [Variation in transfer resistance to cefotaxime, ceftazidime and aztreonam in strains of Acinetobacter sp., Enterobacter sp. and Citrobacter sp. isolated from the same university hospitals]. Babálová M, Krălíková K, Krcméry V, Kubonová K. Cas Lek Cesk; 1996 Mar 20; 135(6):181-4. PubMed ID: 8681362 [Abstract] [Full Text] [Related]
9. [Development of Beta-lactamase resistance in enterobacteria]. Koren J, Vaculíková A. Klin Mikrobiol Infekc Lek; 2006 Jun 20; 12(3):103-7. PubMed ID: 17051471 [Abstract] [Full Text] [Related]
14. [Antibiotic activity and synergism of ceftazidime and netilmicin against gram-negative pathogenic bacteria]. Baumgärtner M, Müller HP, Wundt W. Arzneimittelforschung; 1983 Jun 20; 33(12):1615-9. PubMed ID: 6320836 [Abstract] [Full Text] [Related]
15. Phenotypic characteristics of clinical isolates of Klebsiella pneumoniae & evaluation of available phenotypic techniques for detection of extended spectrum beta-lactamases. Manchanda V, Singh NP, Goyal R, Kumar A, Thukral SS. Indian J Med Res; 2005 Oct 20; 122(4):330-7. PubMed ID: 16394326 [Abstract] [Full Text] [Related]
19. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A, Norwegian ESBL Study Group. J Clin Microbiol; 2007 Jan 20; 45(1):199-205. PubMed ID: 17079502 [Abstract] [Full Text] [Related]